📰 ET Stocks ⚪ NEUTRAL 🕒 09 Oct 2026, 01:57 PM IST

Pidilite shares rise marginally as company appoints Amit Agarwal CFO-designate

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Pidilite shares rise marginally as company appoints Amit Agarwal CFO-designate

📊

Market & Financial Impact: Pidilite Industries shares rose on Friday after the company appointed Amit Agarwal as CFO-designate and Senior Management Personnel, effective October 9, 2026. Agarwal brings over 22 years of finance experience and has previously worked with Pfizer, Hindustan Unilever and Vedanta Resources. He is a Chartered Accountant, Cost Accountant and Company Secretary.

💡

Actionable Insight: Monitor price volume action at market open; check key technical support/resistance levels.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

What is the real impact of 13x jump in cash transfers to women?

The NBFC saga - Part 2: Line drawn in 2006 is reason for the headlines today

Airlines Q2 turbulence: Fewer passengers, rising fares and a crude shock

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

Pidilite shares rise marginally as company appoints Amit Agarwal CFO-designate

🔥 More Live Market Stories

F&O trader claims Rs 61 lakh loss today as he 'couldn’t wake up on time'; avoid BTST, say netizens

[POLICYBZR] Certificate under SEBI (Depositories and Participants) Regulations, 2018 - PB Fintech Limited

[ORCHPHARMA] Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Orchid Pharma Limited

[FINKURVE] Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Finkurve Financial Services Limited

[GEEKAYWIRE] Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Geekay Wires Limited

This exchange stock is a buy on renewed options deal, Morgan Stanley says